Aquatic Capital Management LLC Purchases 14,207 Shares of Cabot Co. (NYSE:CBT)

Aquatic Capital Management LLC boosted its position in Cabot Co. (NYSE:CBT) by 268.7% in the 4th quarter, Holdings Channel reports. The firm owned 19,494 shares of the specialty chemicals company’s stock after buying an additional 14,207 shares during the quarter. Aquatic Capital Management LLC’s holdings in Cabot were worth $1,780,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the company. R Squared Ltd purchased a new stake in shares of Cabot in the fourth quarter worth approximately $26,000. EverSource Wealth Advisors LLC grew its position in Cabot by 37.2% in the 4th quarter. EverSource Wealth Advisors LLC now owns 808 shares of the specialty chemicals company’s stock valued at $74,000 after acquiring an additional 219 shares during the last quarter. GAMMA Investing LLC increased its stake in Cabot by 10.7% in the fourth quarter. GAMMA Investing LLC now owns 1,348 shares of the specialty chemicals company’s stock worth $123,000 after purchasing an additional 130 shares during the period. Manchester Capital Management LLC lifted its position in shares of Cabot by 1,685.1% during the fourth quarter. Manchester Capital Management LLC now owns 1,678 shares of the specialty chemicals company’s stock worth $153,000 after purchasing an additional 1,584 shares during the last quarter. Finally, KBC Group NV boosted its stake in shares of Cabot by 43.1% during the fourth quarter. KBC Group NV now owns 2,046 shares of the specialty chemicals company’s stock valued at $187,000 after purchasing an additional 616 shares during the period. Institutional investors own 93.18% of the company’s stock.

Cabot Stock Down 0.2 %

CBT stock opened at $79.02 on Tuesday. The firm’s fifty day simple moving average is $81.74 and its 200-day simple moving average is $93.34. The company has a market capitalization of $4.28 billion, a P/E ratio of 10.49, a price-to-earnings-growth ratio of 0.74 and a beta of 1.04. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.00 and a quick ratio of 1.29. Cabot Co. has a 12 month low of $73.63 and a 12 month high of $117.46.

Cabot (NYSE:CBT) last released its quarterly earnings data on Monday, February 3rd. The specialty chemicals company reported $1.76 earnings per share for the quarter, beating analysts’ consensus estimates of $1.74 by $0.02. Cabot had a net margin of 10.60% and a return on equity of 26.79%. As a group, equities research analysts forecast that Cabot Co. will post 7.57 earnings per share for the current year.

Wall Street Analyst Weigh In

CBT has been the subject of a number of research analyst reports. JPMorgan Chase & Co. decreased their price objective on shares of Cabot from $105.00 to $85.00 and set an “underweight” rating for the company in a report on Friday, February 21st. Mizuho decreased their price objective on Cabot from $122.00 to $110.00 and set an “outperform” rating for the company in a research note on Tuesday, January 7th. StockNews.com raised shares of Cabot from a “hold” rating to a “buy” rating in a report on Thursday, April 17th. Finally, UBS Group cut their price objective on shares of Cabot from $93.00 to $83.00 and set a “neutral” rating on the stock in a report on Monday, April 7th.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.